Some investors think higher input costs will pinch consumer staples stocks. They're wrong.
The rating agency tells Congress and the White House that the status quo is no longer acceptable when it comes to the balloning budget deficit.
The case for keeping some Japan exposure in your portfolio is clear and compelling.
Phase II trials of a drug can be a profitable undertaking for investors.
Savvy investors can take advantage of market inefficiences and get a price break when they use closed-end funds to trade overseas.
A look at history shows that stocks have outperformed gold over the long haul.
Korean steel maker Posco will benefit from demand related to Japan's reconstruction.
China again is raising the price of rare earth elements. In the long term, this will help stocks like Rare Element Resources as well as the Market Vectors Rare Earth Metals ETF.
With nuclear in trouble, alternative energy will grow, and so will rare earths.
Long-term investors like the odds of Japan pulling through the crisis.